Elisaf, Moses

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial

Hernandez, A. F., Green, J. B., Janmohamed, S., D'Agostino, R. B., Granger, C. B., Jones, N. P., Leiter, L. A., Rosenberg, A. E., Sigmon, K. N., Somerville, M. C., et al. (2018) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,829

Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events: A Systematic Review and Meta-analysis

Rizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., & Elisaf, M. S. (2012) · JAMA

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 960

A review of drug-induced hyponatremia

Liamis, G., Milionis, H., & Elisaf, M. (2008) · American Journal of Kidney Diseases

Electrolyte and hormonal disordersIon Transport and Channel Regulation

Cited by 499

How safe is the use of thiazolidinediones in clinical practice?

Rizos, C., Elisaf, M., Mikhailidis, D., & Liberopoulos, E. (2009) · Expert Opinion on Drug Safety

Diabetes Treatment and ManagementPeroxisome Proliferator-Activated Receptors

Cited by 161

A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease

Kei, A. A., Filippatos, T. D., Tsimihodimos, V., & Elisaf, M. S. (2012) · Metabolism

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 136

Effects of glucagon-like peptide-1 receptor agonists on renal function

Filippatos, T. D., & Elisaf, M. S. (2013) · World Journal of Diabetes

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 97

The effects of orlistat and fenofibrate, alone or in combination, on high‐density lipoprotein subfractions and pre‐beta1‐HDL levels in obese patients with metabolic syndrome

Filippatos, T. D., Liberopoulos, E. N., Kostapanos, M., Gazi, I. F., Papavasiliou, E. C., Kiortsis, D. N., Tselepis, A. D., & Elisaf, M. S. (2008) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentLipoproteins and Cardiovascular Health

Cited by 51

Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implications

Tsimihodimos, V., Kakaidi, V., & Elisaf, M. (2009) · International Journal of Clinical Practice

Potassium and Related DisordersMagnesium in Health and Disease

Cited by 40

Lipoprotein glomerulopathy

Tsimihodimos, V., & Elisaf, M. (2011) · Current Opinion in Lipidology

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 33

The effects of ezetimibe and/or orlistat on triglyceride-rich lipoprotein metabolism in obese hypercholesterolemic patients.

Nakou, E. S., Filippatos, T. D., Agouridis, A. P., Kostara, C., Bairaktari, E. T., & Elisaf, M. S. (2010) · Lipids

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 23